These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15593202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

  • 3. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis.
    Godinho F, Godfrin B, El Mahou S, Navaux F, Zabraniecki L, Cantagrel A.
    Clin Exp Rheumatol; 2004 Apr; 22(3):328-30. PubMed ID: 15144127
    [Abstract] [Full Text] [Related]

  • 4. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
    Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281
    [Abstract] [Full Text] [Related]

  • 5. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.
    Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ.
    J Rheumatol; 2006 Jan; 33(1):24-30. PubMed ID: 16395746
    [Abstract] [Full Text] [Related]

  • 6. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis.
    Hansen KE, Cush J, Singhal A, Cooley DA, Cohen S, Patel SR, Genovese M, Sundaramurthy S, Schiff M.
    Arthritis Rheum; 2004 Apr 15; 51(2):228-32. PubMed ID: 15077264
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of autoantibodies during prolonged treatment with infliximab.
    Louis M, Rauch J, Armstrong M, Fitzcharles MA.
    J Rheumatol; 2003 Dec 15; 30(12):2557-62. PubMed ID: 14719194
    [Abstract] [Full Text] [Related]

  • 9. Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab.
    Marchesoni A, Arreghini M, Panni B, Battafarano N, Uziel L.
    Rheumatology (Oxford); 2003 Jan 15; 42(1):193-4. PubMed ID: 12509641
    [No Abstract] [Full Text] [Related]

  • 10. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.
    Allanore Y, Sellam J, Batteux F, Job Deslandre C, Weill B, Kahan A.
    Clin Exp Rheumatol; 2004 Jan 15; 22(6):756-8. PubMed ID: 15638051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infliximab induced chilblain lupus in a patient with rheumatoid arthritis.
    Richez C, Dumoulin C, Schaeverbeke T.
    J Rheumatol; 2005 Apr 15; 32(4):760-1. PubMed ID: 15801042
    [No Abstract] [Full Text] [Related]

  • 15. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.
    Kiely PD, Johnson DM.
    Rheumatology (Oxford); 2002 Jun 15; 41(6):631-7. PubMed ID: 12048288
    [Abstract] [Full Text] [Related]

  • 16. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV, Alamanos Y, Nikas SN, Bougias DV, Temekonidis TI, Drosos AA.
    Am J Med; 2005 May 15; 118(5):515-20. PubMed ID: 15866254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
    Thonhofer R, Gaugg M, Kriessmayr M, Neumann HJ, Erlacher L.
    Ann Rheum Dis; 2005 Jul 15; 64(7):1098-9. PubMed ID: 15958773
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide.
    Martinez-Taboada VM, Rodriguez-Valverde V, Gonzalez-Vilchez F, Armijo JA.
    Rheumatology (Oxford); 2004 Nov 15; 43(11):1451-3. PubMed ID: 15501999
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.